KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) Equity Average (2016 - 2025)

Historic Equity Average for Medpace Holdings (MEDP) over the last 10 years, with Q3 2025 value amounting to $233.0 million.

  • Medpace Holdings' Equity Average fell 7167.29% to $233.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $233.0 million, marking a year-over-year decrease of 7167.29%. This contributed to the annual value of $692.2 million for FY2024, which is 4645.52% up from last year.
  • Medpace Holdings' Equity Average amounted to $233.0 million in Q3 2025, which was down 7167.29% from $383.0 million recorded in Q2 2025.
  • In the past 5 years, Medpace Holdings' Equity Average ranged from a high of $925.5 million in Q4 2021 and a low of $233.0 million during Q3 2025
  • Moreover, its 5-year median value for Equity Average was $615.2 million (2024), whereas its average is $600.6 million.
  • In the last 5 years, Medpace Holdings' Equity Average surged by 9437.87% in 2024 and then plummeted by 7167.29% in 2025.
  • Quarter analysis of 5 years shows Medpace Holdings' Equity Average stood at $925.5 million in 2021, then plummeted by 60.22% to $368.1 million in 2022, then soared by 39.88% to $514.9 million in 2023, then soared by 65.75% to $853.5 million in 2024, then crashed by 72.7% to $233.0 million in 2025.
  • Its Equity Average stands at $233.0 million for Q3 2025, versus $383.0 million for Q2 2025 and $709.6 million for Q1 2025.